Search
for
Sort by
Research 271–300 of 1000+
- Long-term use of 5α-reductase inhibitors and the risk of male breast cancer
- Considerations in genetic counseling of transgender patients: Cultural competencies and altered disease risk profiles
- Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome
- Cronkhite-Canada syndrome associated with colon cancer metastatic to liver
- Effect of ethanol extract of Zapoteca portoricensis stem on liver, kidney and prostatic biomarkers of testosterone-induced benign prostate hyperplasia (BPH) in male albino rats
- Association Between 5-Alpha Reductase Inhibitor Use and The Risk of Depression: A Meta-Analysis.
- Dermatoses of Pregnancy - Clues to Diagnosis, Fetal Risk and Therapy
- Hair, Hormones, and High-Risk Prostate Cancer
- Polycystic ovary syndrome: Pathophysiology, Symptoms, Risk factors, and Pharmacological treatment
- Physician Awareness of the Safe Use of Cyproterone Acetate in Europe: A Survey on the Effectiveness of Additional Risk Minimization Measures
- In vitro expansion of human mesenchymal stem cells and hepatocytes using purified platelet derived growth factors, a potential therapeutic modality for liver fibrosis
- Metabolic syndrome and the skin: a more than superficial association. Reviewing the association between skin diseases and metabolic syndrome and a clinical decision algorithm for high risk patients
- Calcineurin-based immunosuppression in renal transplantation : focus on efficacy, the role of steroids, and the cardiovascular risk
- Endocrine care of transpeople part I. A review of cross-sex hormonal treatments, outcomes and adverse effects in transmen
- Circulating and/or cutaneous irisin resistance: A novel link among androgenetic alopecia, comorbid metabolic syndrome and cardiovascular risks
- Cell type‐specific actions of thyroid hormones in nonalcoholic steatohepatitis and liver fibrosis
- Peri-operative Antithrombotic Therapy in Hair Transplantation
- Progressive Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) from a Young Age Due to a Rare Genetic Disorder, Familial Partial Lipodystrophy: A Case Report and Review of the Literature
- Prevalence of hepatic steatosis in women with polycystic ovary syndrome
- Cutaneous manifestations of anabolic-androgenic steroid use in athletes
- Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men
- Chemotherapy of psoriasis and other skin disorders with oral retinoids
- Recommendations of endocrine treatment for patients with gender dysphoria
- Evaluating the hormonal and biochemical markers in womens with polycystic ovarian syndrome PCOS in Missan Province
- Three cases of liver toxicity with a dietary supplement intended to stop hair loss.
- Long-term complications of Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN): the spectrum of chronic problems in patients who survive an episode of SJS/TEN necessitates multidisciplinary follow-up
- miR-761-hepcidin/Gpx4 pathway contribute to unexplained liver dysfunction in polycystic ovary syndrome by regulating liver iron overload and ferroptosis
- Metabolic dysfunction in female mice with disruption of 5α-reductase 1
- “Low‐risk” myelodysplastic neoplasm (MDS): Time for a name change?
- A population pharmacokinetic model for individualized regimens of finasteride according to CYP3A5 genotype and liver function